Stomach Ballon Systems Market Report 2026

Stomach Ballon Systems Market Overview

• Stomach Ballon Systems market size has reached to $1.43 billion in 2025 • Expected to grow to $2.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Obesity Prevalence Driving Growth Of The Market Due To Unhealthy Diets And Sedentary Lifestyles • Market Trend: Advancing Minimally Invasive Obesity Management Through Swallowable Gastric Balloon Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stomach Ballon Systems Market?

A stomach balloon system (intragastric balloon) is a non-surgical weight-loss procedure in which a soft balloon is placed in the stomach and filled with saline or gas to reduce the available space for food. It helps people feel full faster, leading to reduced food intake and gradual weight loss under medical supervision. The main product types of stomach balloon systems include single balloon systems, dual balloon systems, adjustable balloon systems, and Spatz balloon systems. Single balloon systems refer to intragastric balloon devices consisting of a single inflatable balloon placed in the stomach to promote satiety by reducing gastric volume and supporting non surgical weight loss. These systems are made using material types including silicone based balloons, polyurethane based balloons, saline filled balloons, and gas filled balloons and are designed for patient types such as adult patients, pediatric patients, and geriatric patients. They are used in procedure types including endoscopic placement, non surgical weight loss procedure, and temporary gastric occupancy therapy and are utilized by end users including hospitals, ambulatory surgical centers, specialty bariatric clinics, and medical spas and wellness centers.

What Is The Stomach Ballon Systems Market Growth Forecast?

The stomach ballon systems market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to adoption of ai-enabled patient monitoring systems, development of biodegradable gastric balloon technologies, increasing use of combination therapies with anti-obesity drugs, expansion of telehealth-based follow-up care models, shift toward personalized metabolic treatment approaches. Major trends in the forecast period include rise of swallowable gastric balloon technologies, increasing adoption of minimally invasive endoscopic bariatric procedures, growing preference for adjustable and long-duration intragastric balloon systems, integration of remote digital monitoring for post-procedure weight management, expansion of outpatient-based bariatric treatment models.

Global Stomach Ballon Systems Market Segmentation

1) By Product Type: Single Balloon Systems; Dual Balloon Systems; Adjustable Balloon Systems; Spatz Balloon Systems 2) By Material Type: Silicone Based Balloons; Polyurethane Based Balloons; Saline Filled Balloons; Gas Filled Balloons 3) By Patient Type: Adult Patients; Pediatric Patients; Geriatric Patients 4) By Procedure Type: Endoscopic Placement; Non Surgical Weight Loss Procedure; Temporary Gastric Occupancy Therapy 5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Bariatric Clinics; Medical Spas And Wellness Centers Subsegments: 1) By Single Balloon Systems: Saline Filled Balloon; Gas Filled Balloon; Endoscopic Placement Balloon; Swallowable Balloon 2) By Dual Balloon Systems: Connected Dual Balloon; Independent Dual Balloon; Adjustable Volume Dual Balloon; Endoscopic Dual Balloon 3) By Adjustable Balloon Systems: Volume Adjustable Balloon; Pressure Adjustable Balloon; Remote Controlled Balloon; Refillable Balloon 4) By Spatz Balloon Systems: Adjustable Volume Spatz Balloon; Long Duration Spatz Balloon; Endoscopic Spatz Balloon; Repositionable Spatz Balloon

What Are The Drivers Of The Stomach Ballon Systems Market?

The rising prevalence of obesity is expected to propel the growth of the stomach balloon systems market going forward. Obesity is a medical condition in which excess body fat accumulates to a level that can harm health, usually indicated by a BMI of 30 or higher. Obesity is increasing mainly due to high consumption of processed, calorie-dense foods combined with reduced physical activity in modern sedentary lifestyles, leading to more energy intake than the body burns. Stomach balloon systems help treat obesity by placing a temporary inflatable balloon in the stomach that reduces available space for food, making a person feel full faster and thereby lowering calorie intake to support weight loss alongside diet and lifestyle changes. For instance, in March 2025, according to the World Obesity Federation, a UK-based membership organization, by 2030, nearly 3 billion adults, around 50% of the global adult population, will be affected by overweight or obesity. Therefore, the rising prevalence of obesity is driving the growth of the stomach balloon systems market. The increasing adoption of minimally invasive procedures is expected to propel the growth of the stomach balloon systems market going forward. Minimally invasive procedures are medical treatments performed through small incisions or natural openings using specialized tools to reduce pain, tissue damage, and recovery time compared to open surgery. Minimally invasive procedures are increasing due to advancements in medical technology, which make them safer, more precise, and suitable for a wider range of treatments. Stomach balloon systems support minimally invasive procedures by providing a non-surgical, endoscopic, or swallowable method to reduce stomach capacity and promote weight loss without large incisions, thereby lowering risk, pain, and recovery time. For instance, in September 2023, according to the National Library of Medicine, a US-based federal government agency, 7,733 robotic surgical systems were installed worldwide, and more than 10 million robotic surgeries have been carried out. Therefore, the increasing adoption of minimally invasive procedures is driving the growth of the stomach balloon systems market.

Key Players In The Global Stomach Ballon Systems Market

Major companies operating in the stomach ballon systems market are Boston Scientific Corporation; Allurion Technologies Inc.; Spatz Medical Ltd.; Helioscopie S.A.S.; Vyome Holdings Inc.; Endalis SA; Districlass Medical SA; Silimed Indústria de Implantes Ltda.

Global Stomach Ballon Systems Market Trends and Insights

Major companies operating in the stomach balloon systems market are focusing on developing innovative solutions, such as swallowable gastric balloons, to enable minimally invasive, non-surgical weight loss options for effective obesity management. A swallowable gastric balloon is a temporary, non-surgical weight-loss device that is swallowed as a capsule and inflated in the stomach to reduce food intake by increasing satiety. For instance, in February 2026, Allurion Technologies, Inc., a US-based healthcare technology company, received an FDA approval for a swallowable gastric balloon. It is now called the Allurion Gastric Balloon System for short-term weight loss in adults ages 22 to 65 with obesity and a BMI between 30 and 40 who have tried and not succeeded with at least one weight-loss program. It is used with lifestyle modification therapy and is designed to stay in the stomach for about 4 months before passing naturally.

Regional Outlook

North America was the largest region in the stomach ballon systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stomach Ballon Systems Market?

The stomach balloon systems market consists of sales of the triple balloon systems, swallowable gastric balloons, endoscopically placed balloons, and fluid-filled intragastric balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the products, whether to other entities (including hospitals, clinics, ambulatory surgical centers, wholesalers, distributors, and healthcare providers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods, such as endoscopic placement support and post-procedure monitoring.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stomach Ballon Systems Market Report 2026?

The stomach ballon systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stomach ballon systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.